Capital Wealth Alliance, LLC Invitae Corp Transaction History

Capital Wealth Alliance, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$1.9 - $8.63 $33,440 - $151,888	17,600 Added 33.59%	70,000 $173,000
Q2 2022 Sep 23, 2022	BUY	$2.13 - $9.01 $111,612 - $472,124	52,400 New	52,400 $127,000
Q2 2022 Aug 02, 2022	SELL	$2.13 - $9.01 $111,612 - $472,124	-52,400 Closed	0 $0
Q4 2021 Jan 27, 2022	SELL	$14.7 - $28.67 $111,720 - $217,892	-7,600 Reduced 12.67%	52,400 $800,000
Q3 2021 Nov 02, 2021	BUY	$24.31 - $33.6 $486,200 - $672,000	20,000 Added 50.0%	60,000 $1.65 Million

Q2 2021 Aug 02, 2021	SELL	$26.09 - $40.4 $5,218 - $8,080	-200 Reduced 0.5%	40,000 $1.15 Million
Q1 2021 May 07, 2021	SELL	$33.06 - $56.93 $694,260 - $1.2 Million	-21,000 Reduced 34.31%	40,200 $1.54 Million
Q4 2020 Feb 05, 2021	BUY	$39.09 - $57.4 $2.39 Million - $3.51 Million	61,200 New	61,200 $3.28 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Capital Wealth Alliance, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Wealth Alliance, LLC with notifications on news.